Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims Study.

Varnado, Oralee J; Manjelievskaia, Janna; Ye, Wenyu; Perry, Allison; Schuh, Kory; Wenzel, Richard

Varnado, Oralee J; Manjelievskaia, Janna; Ye, Wenyu; Perry, Allison; Schuh, Kory; Wenzel, Richard.

Afiliación

Varnado OJ; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA.
Manjelievskaia J; Watson Health Life Sciences, Research & Analytics, IBM Watson Health, Cambridge, MA, USA.
Ye W; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA.
Perry A; Watson Health Life Sciences, Research & Analytics, IBM Watson Health, Cambridge, MA, USA.
Schuh K; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA.
Wenzel R; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA.

Patient Prefer Adherence ; 16: 821-839, 2022.

Article en En | MEDLINE | ID: mdl-35378732

Palabras clave

CGRP; adherence; discontinuation; persistence; switch

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Patient Prefer Adherence Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google